Celgene acquired by Bristol Myers Squibb for 74 Billion USD.
Celgene is a Bio-Pharmaceutical company and headquarters is in New Jersey, USA.
Bristol-Myers Squibb is USA based health care and pharmaceutical multi-national company. Headquarters is in New York, USA.
Acquired By
Bristol-Myers Squibb
Year of Acquisition
2019
Transaction Type
Website
Acqusition Price
74,000.00 Million USD
Acquisition Percentage
100
Headquarters of Companies
USA